Here are the DEF 14A proxy statements from Eastman Chemical Company (EMN) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow EMN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full EMN filings page.
Eastman Chemical Company is asking stockholders to vote at its virtual 2026 Annual Meeting on May 7, 2026. Proposals include electing eleven directors for one-year terms, ratifying PricewaterhouseCoopers LLP as auditor for 2026, an advisory "Say on Pay" vote on executive compensation, approval of the 2026 Omnibus Stock Compensation Plan, and an advisory vote on a stockholder proposal to lower the threshold for calling special meetings to 10%, which the Board opposes.
Eastman highlights its innovation-driven, sustainability-focused growth strategy and reports 2025 results of $8.8 billion in sales, $930 million adjusted EBIT, $474 million net earnings, diluted EPS of $4.10, and adjusted diluted EPS of $5.42. The company generated $970 million in net cash from operating activities and returned approximately $500 million to stockholders through dividends and share repurchases.
The Board emphasizes succession planning, board refreshment, and governance. Ten of eleven nominees are independent, average tenure is 9.7 years, and the Board recorded 99% average attendance at 34 Board and Committee meetings in 2025. Independent committees oversee audit, compensation, governance, finance, and environmental, safety, and sustainability matters, with strong focus on risk management, human capital, and long-term sustainability initiatives.